Integra Lifesciences Holdings (IART) Price to Book (2009 - 2026)

Integra Lifesciences Holdings has disclosed Price to Book across 18 years of filings, most recently posting 1.34 for Q2 2026.

• In Q2 2026, Price to Book rose 45.45% year-over-year to 1.34; the TTM figure through Jun 2026 stood at 1.34 (up 45.45% YoY), while the FY2025 annual figure was 0.93, down 18.15% from the prior year.
• Price to Book came in at 1.34 for Q2 2026 at Integra Lifesciences Holdings, up from 0.7 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 3.31 in Q1 2022 to a low of 0.7 in Q1 2026.
• Average Price to Book over 5 years is 1.71, with a median of 1.61 recorded in 2024.
• Year-over-year, Price to Book sank 51.26% in 2024 and jumped 45.45% in 2026.
• Over 5 years, Price to Book stood at 2.54 in 2022, then fell by 15.43% to 2.15 in 2023, then tumbled by 47.17% to 1.13 in 2024, then fell by 18.15% to 0.93 in 2025, then surged by 44.31% to 1.34 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 1.34 in Q2 2026, 0.7 in Q1 2026, and 0.93 in Q4 2025.